ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Nasdaq: ALNY · CIK 0001178670 · United States
Every official ALNYLAM PHARMACEUTICALS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ALNY filings
ALNYLAM PHARMACEUTICALS, INC. documents
- ALNYLAM PHARMACEUTICALS, INC. 10-K 2026ALNY 10-K 2026: annual report for fiscal 2026
- ALNYLAM PHARMACEUTICALS, INC. 10-K 2025ALNY 10-K 2025: annual report for fiscal 2025
- ALNYLAM PHARMACEUTICALS, INC. 10-K 2024ALNY 10-K 2024: annual report for fiscal 2024
- ALNYLAM PHARMACEUTICALS, INC. 10-K 2023ALNY 10-K 2023: annual report for fiscal 2023
- ALNYLAM PHARMACEUTICALS, INC. 10-K 2022ALNY 10-K 2022: annual report for fiscal 2022
- ALNYLAM PHARMACEUTICALS, INC. 10-Q 2026ALNY 10-Q 2026: quarterly report for fiscal 2026
- ALNYLAM PHARMACEUTICALS, INC. 10-Q 2025ALNY 10-Q 2025: quarterly report for fiscal 2025
- ALNYLAM PHARMACEUTICALS, INC. 10-Q 2024ALNY 10-Q 2024: quarterly report for fiscal 2024
- ALNYLAM PHARMACEUTICALS, INC. 10-Q 2023ALNY 10-Q 2023: quarterly report for fiscal 2023
- ALNYLAM PHARMACEUTICALS, INC. 10-Q 2022ALNY 10-Q 2022: quarterly report for fiscal 2022
- ALNYLAM PHARMACEUTICALS, INC. 8-K 2026ALNY 8-K 2026: current report for fiscal 2026
- ALNYLAM PHARMACEUTICALS, INC. 8-K 2025ALNY 8-K 2025: current report for fiscal 2025
- ALNYLAM PHARMACEUTICALS, INC. 8-K 2024ALNY 8-K 2024: current report for fiscal 2024
- ALNYLAM PHARMACEUTICALS, INC. 8-K 2023ALNY 8-K 2023: current report for fiscal 2023
- ALNYLAM PHARMACEUTICALS, INC. 8-K 2022ALNY 8-K 2022: current report for fiscal 2022
- ALNYLAM PHARMACEUTICALS, INC. DEF 14A 2026ALNY DEF 14A 2026: proxy statement for fiscal 2026
- ALNYLAM PHARMACEUTICALS, INC. DEF 14A 2025ALNY DEF 14A 2025: proxy statement for fiscal 2025
- ALNYLAM PHARMACEUTICALS, INC. DEF 14A 2024ALNY DEF 14A 2024: proxy statement for fiscal 2024
- ALNYLAM PHARMACEUTICALS, INC. DEF 14A 2023ALNY DEF 14A 2023: proxy statement for fiscal 2023
- ALNYLAM PHARMACEUTICALS, INC. DEF 14A 2022ALNY DEF 14A 2022: proxy statement for fiscal 2022
- ALNYLAM PHARMACEUTICALS, INC. Form 4 2026ALNY Form 4 2026: insider trading filing for fiscal 2026
- ALNYLAM PHARMACEUTICALS, INC. Form 4 2025ALNY Form 4 2025: insider trading filing for fiscal 2025
- ALNYLAM PHARMACEUTICALS, INC. Form 4 2024ALNY Form 4 2024: insider trading filing for fiscal 2024
- ALNYLAM PHARMACEUTICALS, INC. Form 4 2023ALNY Form 4 2023: insider trading filing for fiscal 2023
- ALNYLAM PHARMACEUTICALS, INC. Form 4 2022ALNY Form 4 2022: insider trading filing for fiscal 2022
- ALNYLAM PHARMACEUTICALS, INC. S-1 2026ALNY S-1 2026: registration statement for fiscal 2026
- ALNYLAM PHARMACEUTICALS, INC. S-1 2025ALNY S-1 2025: registration statement for fiscal 2025
- ALNYLAM PHARMACEUTICALS, INC. S-1 2024ALNY S-1 2024: registration statement for fiscal 2024
- ALNYLAM PHARMACEUTICALS, INC. S-1 2023ALNY S-1 2023: registration statement for fiscal 2023
- ALNYLAM PHARMACEUTICALS, INC. S-1 2022ALNY S-1 2022: registration statement for fiscal 2022
- ALNYLAM PHARMACEUTICALS, INC. 13F 2026ALNY 13F 2026: institutional holdings for fiscal 2026
- ALNYLAM PHARMACEUTICALS, INC. 13F 2025ALNY 13F 2025: institutional holdings for fiscal 2025
- ALNYLAM PHARMACEUTICALS, INC. 13F 2024ALNY 13F 2024: institutional holdings for fiscal 2024
- ALNYLAM PHARMACEUTICALS, INC. 13F 2023ALNY 13F 2023: institutional holdings for fiscal 2023
- ALNYLAM PHARMACEUTICALS, INC. 13F 2022ALNY 13F 2022: institutional holdings for fiscal 2022
More companies